Clinical Trials
Showing all 9 results
Blood Disorders|Cancer
New Investigation Oral Drug for Previously Treated CLL/SLL Patients
This trial is currently enrollingThis is a phase 3 open-label, randomized study to assess the safety and effectiveness of a fixed duration of the investigational study drug plus standard of...
Cancer|Colon and Rectal Conditions|Gastroenterology
Investigational Drug for Adults with Advanced Solid Tumors
This trial is currently enrollingThe primary purpose of this clinical research study is to evaluate the safety and tolerability of investigational drug, BBP-398. BBP-398 is an oral...
Cancer|Lung Disorders|Pulmonary Medicine
Investigational drug for treatment of advanced Non-Small Cell Lung Cancer
This trial is currently enrollingThis study will test the safety of an investigational oral drug, BBP-398, combined with an FDA approved dose of Nivolumab. The purpose of this Phase I study...
Cancer
A New Investigational Drug for Multiple Myeloma
This trial is currently enrollingThis study is evaluating the safety and tolerability of investigational drug, modakafulsp alfa, in combination with standard of care therapy for adult...
Cancer|Chest Medicine|Lung Disorders|Pulmonary Medicine
Randomized Trial for Non-small Cell Lung Cancer after Progression on EGFR TKI
This trial is currently enrollingThis study will compare the safety and effectiveness of patritumab deruxtecan to standard of care platinum-based chemotherapy. Patients will be randomized...
Cancer|Gastroenterology|Gynecology and Obstetrics|Lung Disorders|Urology
A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors
This trial is currently enrollingThis study will test the safety and effectiveness of an investigational drug, OBI-3424, given once every three weeks by intravenous (IV) infusion in patients...
Cancer|Radiation Oncology
Hyperfractioned Regional Nodal Irradiation for women with invasive breast cancer
This trial is currently enrollingThis study will test the safety and effectiveness of regional-nodal irradiation given over 3 weeks compared to the standard of 5 weeks.
Cancer|Radiation Oncology
Local consolidative therapy (LCT) for selective oligometastatic cancers
This trial is currently enrollingThe goal of this study is to learn if giving local consolidative therapy (LCT) up-front can better help to control oligometastatic disease, compared to a...
Cancer|Radiation Oncology
Partial Breast Irradiation in Women with Early Stage Breast Cancer
This trial is currently enrollingThis study will test the safety and effectiveness of one week of treatment with partial breast irradiation compared to the current standard of care regimen...